Literature DB >> 25482617

SLUG: Critical regulator of epithelial cell identity in breast development and cancer.

Sarah Phillips1, Charlotte Kuperwasser.   

Abstract

SLUG, a member of the SNAIL family of transcriptional repressors, is known to play a diverse number of roles in the cell, and its deregulation has been observed in a variety of cancers including breast. Here, we focus on SLUG's role as a master regulator of mammary epithelial cell (MEC) fate and lineage commitment in the normal mammary gland, and discuss how aberrant SLUG expression can influence breast tumor formation, phenotype, and progression. Specifically, we discuss SLUG's involvement in MEC differentiation, stemness, cellular plasticity, and the epithelial to mesenchymal transition (EMT), and highlight the complex connection between these programs during development and disease progression. Undoubtedly, delineating how molecular factors influence lineage identity and cell-state dynamics in the normal mammary gland will contribute to our understanding of breast tumor heterogeneity.

Entities:  

Keywords:  BCSC, Breast Cancer Stem Cell; BM, Basement Membrane; BRCA1, Breast Cancer Associated 1; CK, Cytokeratin; CSC, Cancer Stem Cell; E-CAD, E-Cadherin; EMT; EMT, Epithelial to Mesenchymal Transition; ERα, Estrogen Receptor; HDAC, Histone Deacetylasae; HMECs, Human Mammary Epithelial Cells; IHC, Immunohistochemical; LSD1, Lysine Specific Demethylase 1.; ME, Myoepithelial; MEC, Mammary Epithelial Cell; MaSC, Mammary Stem Cell; SLUG; SMA, Smooth Muscle Actin; SNAG, Snai.Gfi-1; WT, Wild type; breast cancer; cellular plasticity; differentiation; mammary stem cells

Mesh:

Substances:

Year:  2014        PMID: 25482617      PMCID: PMC4594335          DOI: 10.4161/19336918.2014.972740

Source DB:  PubMed          Journal:  Cell Adh Migr        ISSN: 1933-6918            Impact factor:   3.405


  114 in total

1.  Mammary collective cell migration involves transient loss of epithelial features and individual cell migration within the epithelium.

Authors:  Andrew J Ewald; Robert J Huebner; Hildur Palsdottir; Jessie K Lee; Melissa J Perez; Danielle M Jorgens; Andrew N Tauscher; Kevin J Cheung; Zena Werb; Manfred Auer
Journal:  J Cell Sci       Date:  2012-02-17       Impact factor: 5.285

2.  Distinct stem cells contribute to mammary gland development and maintenance.

Authors:  Alexandra Van Keymeulen; Ana Sofia Rocha; Marielle Ousset; Benjamin Beck; Gaëlle Bouvencourt; Jason Rock; Neha Sharma; Sophie Dekoninck; Cédric Blanpain
Journal:  Nature       Date:  2011-10-09       Impact factor: 49.962

3.  Gene expression profiling of breast cell lines identifies potential new basal markers.

Authors:  E Charafe-Jauffret; C Ginestier; F Monville; P Finetti; J Adélaïde; N Cervera; S Fekairi; L Xerri; J Jacquemier; D Birnbaum; F Bertucci
Journal:  Oncogene       Date:  2006-04-06       Impact factor: 9.867

4.  Depletion of BRCA1 impairs differentiation but enhances proliferation of mammary epithelial cells.

Authors:  Saori Furuta; Xianzhi Jiang; Bingnan Gu; Eric Cheng; Phang-Lang Chen; Wen-Hwa Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-20       Impact factor: 11.205

5.  A gene signature in breast cancer.

Authors:  Francois Bertucci; Nathalie Cervera; Daniel Birnbaum
Journal:  N Engl J Med       Date:  2007-05-03       Impact factor: 91.245

6.  Epigenetic alteration of the NF-κB-inducing kinase (NIK) gene is involved in enhanced NIK expression in basal-like breast cancer.

Authors:  Mizuki Yamamoto; Taku Ito; Takafumi Shimizu; Takaomi Ishida; Kentaro Semba; Shinya Watanabe; Noritaka Yamaguchi; Jun-Ichiro Inoue
Journal:  Cancer Sci       Date:  2010-08-24       Impact factor: 6.716

7.  A method for quantifying normal human mammary epithelial stem cells with in vivo regenerative ability.

Authors:  Peter Eirew; John Stingl; Afshin Raouf; Gulisa Turashvili; Samuel Aparicio; Joanne T Emerman; Connie J Eaves
Journal:  Nat Med       Date:  2008-11-23       Impact factor: 53.440

Review 8.  Basal breast cancer: a complex and deadly molecular subtype.

Authors:  F Bertucci; P Finetti; D Birnbaum
Journal:  Curr Mol Med       Date:  2012-01       Impact factor: 2.222

9.  Mapping the cellular and molecular heterogeneity of normal and malignant breast tissues and cultured cell lines.

Authors:  Patrica J Keller; Amy F Lin; Lisa M Arendt; Ina Klebba; Ainsely D Jones; Jenny A Rudnick; Theresa A DiMeo; Hannah Gilmore; Douglas M Jefferson; Roger A Graham; Stephen P Naber; Stuart Schnitt; Charlotte Kuperwasser
Journal:  Breast Cancer Res       Date:  2010-10-21       Impact factor: 6.466

10.  Interaction with Suv39H1 is critical for Snail-mediated E-cadherin repression in breast cancer.

Authors:  C Dong; Y Wu; Y Wang; C Wang; T Kang; P G Rychahou; Y-I Chi; B M Evers; B P Zhou
Journal:  Oncogene       Date:  2012-05-07       Impact factor: 9.867

View more
  41 in total

Review 1.  The ETS family of oncogenic transcription factors in solid tumours.

Authors:  Gina M Sizemore; Jason R Pitarresi; Subhasree Balakrishnan; Michael C Ostrowski
Journal:  Nat Rev Cancer       Date:  2017-04-28       Impact factor: 60.716

2.  MicroRNA-590-3p inhibits invasion and metastasis in triple-negative breast cancer by targeting Slug.

Authors:  Meisi Yan; Leiguang Ye; Xinxin Feng; Runze Shi; Zhen Sun; Zhigao Li; Tong Liu
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

3.  The SIRT2 Deacetylase Stabilizes Slug to Control Malignancy of Basal-like Breast Cancer.

Authors:  Wenhui Zhou; Thomas K Ni; Ania Wronski; Benjamin Glass; Adam Skibinski; Andrew Beck; Charlotte Kuperwasser
Journal:  Cell Rep       Date:  2016-10-25       Impact factor: 9.423

4.  MicroRNA-199a-3p promotes drug sensitivity in triple negative breast cancer by down-regulation of BRCA1.

Authors:  John Chi-Wang Ho; Jiawei Chen; Isabella Wai-Yin Cheuk; Man-Ting Siu; Vivian Yvonne Shin; Ava Kwong
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

Review 5.  Essential role of aerobic glycolysis in epithelial-to-mesenchymal transition during carcinogenesis.

Authors:  Chandra Prakash Prasad; Ajay Gogia; Atul Batra
Journal:  Clin Transl Oncol       Date:  2022-06-25       Impact factor: 3.340

6.  Inhibition of lncRNA RET enhances radio-sensitivity of tumor cells via miR-3179/Slug/PTEN axis.

Authors:  Xinxin Liang; Xueping Li; Ping Wang; Zhongmin Chen; Ziyan Yan; Xingkun Ao; Yuhao Liu; Jiaojiao Zhu; Tingting Xi; Shenghui Zhou; Zhongqiu Li; Chao Li; Maoxiang Zhu; Ping-Kun Zhou; Yongqing Gu
Journal:  Toxicol Res (Camb)       Date:  2022-04-01       Impact factor: 2.680

7.  Slug silencing inhibited perineural invasion through regulation of EMMPRIN expression in human salivary adenoid cystic carcinoma.

Authors:  Baolei Wu; Jianhua Wei; Zhiqiang Hu; Chun Shan; Lei Wang; Chenping Zhang; Xi Yang; Xinjie Yang; Delin Lei
Journal:  Tumour Biol       Date:  2015-09-09

Review 8.  Linking EMT programmes to normal and neoplastic epithelial stem cells.

Authors:  Arthur W Lambert; Robert A Weinberg
Journal:  Nat Rev Cancer       Date:  2021-02-05       Impact factor: 69.800

9.  ETS-Related Gene Expression in Healthy Femoral Arteries With Focal Calcifications.

Authors:  Francesco Vasuri; Sabrina Valente; Ilenia Motta; Alessio Degiovanni; Carmen Ciavarella; Gianandrea Pasquinelli
Journal:  Front Cell Dev Biol       Date:  2021-06-16

10.  Ruyiping formula inhibits metastasis via the microRNA-134-SLUG axis in breast cancer.

Authors:  Ziwei Jiang; Lixia Pei; Ying Xie; Qun Ye; Xiaoqiang Liang; Yiyi Ye; Sheng Liu
Journal:  BMC Complement Med Ther       Date:  2021-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.